Xilio Therapeutics, Inc. (XLO) Shareholders’ equity 2024–2025
Xilio Therapeutics, Inc. (XLO) shareholders’ equity at each fiscal year-end, per SEC filings.
$35.3MFY2025 · since FY2024: $17.6M → $35.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $35.3M | +100.4% |
| FY2024 | $17.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice